UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000026493
Receipt number R000030429
Scientific Title Phase I study safety and immunogenicity of vaccination with XAGE1 long peptides in patients with advanced lung adenocarcinoma
Date of disclosure of the study information 2017/05/22
Last modified on 2020/03/13 00:52:03

No. Disposal Last modified on Item of update
1 Insert 2017/03/10 10:43:16
2 Update 2017/05/06 12:16:06 Date of disclosure of the study information
3 Update 2017/05/22 07:44:54 Recruitment status
Anticipated trial start date
4 Update 2017/05/22 07:48:01 Date of protocol fixation
5 Update 2018/06/11 07:53:31 Recruitment status
6 Update 2018/09/11 07:23:21 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
7 Update 2018/09/11 07:24:32 Email
Email
8 Update 2019/03/12 12:53:58 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Institute
Department
Division
Organization
Organization
Address
Address
Tel
Email
9 Update 2019/03/12 12:54:39 Number of participants that the trial has enrolled
10 Update 2019/03/12 12:57:43 Date of IRB
Date analysis concluded
11 Update 2020/03/12 22:31:05
Last name of contact person

Last name of contact person
Email
Name of person sending information
Name of person sending information
Email
12 Update 2020/03/13 00:43:13 UMIN ID1
13 Update 2020/03/13 00:52:03 Email1
Email